© Copyright - Newspaper WordPress Theme by TagDiv
Nystatin
Also known as / Synonyms: Nystatin Oral Suspension, Polyene Antifungal
Topical antifungal oral drops that treat oral thrush (candidiasis) and denture stomatitis in infants and adults.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment of oral candidiasis (thrush) in the oral cavity caused by Candida albicans and other Candida species.
- Denture stomatitis (chronic atrophic candidiasis) associated with removable full or partial dentures.
- Oral candidiasis in infants and neonates.
- Prophylaxis of oral candidiasis in immunocompromised patients (HIV/AIDS, post-chemotherapy, organ transplant recipients) and patients using inhaled corticosteroids.
Contraindications (Do Not Use If…)
History of hypersensitivity to nystatin or any formulation components.
Important Clinical Precautions & Warnings
- Swish and swallow technique: retain the suspension in the mouth for as long as possible (several minutes) before swallowing; in infants, paint 1 mL on each side of the mouth with a dropper.
- Continue therapy for at least 48 hours after symptoms resolve: standard course is 7 to 14 days; stopping prematurely often leads to fungal relapse.
- Denture disinfection: dentures must be soaked overnight in nystatin suspension or a chlorhexidine/dilute hypochlorite solution; otherwise, the colonized acrylic denture will immediately reinfect the mucosa.
- High sucrose content: many oral suspensions contain substantial amounts of sucrose (up to 50%); practice meticulous oral hygiene to prevent dental caries during multi-week regimens.
- Minimal systemic absorption: nystatin is not absorbed from the intact gastrointestinal tract; acts purely topically.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safe and approved in neonates and infants; dose 100,000 to 200,000 units 4 times daily. Geriatric: Safe and effective for denture stomatitis; ensure simultaneous denture disinfection.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Diarrhea, nausea, vomiting, gastrointestinal distress (with high swallowed doses), and oral irritation.
Serious Side Effects — Seek Urgent Medical Care
Severe cutaneous hypersensitivity, Stevens-Johnson syndrome (extremely rare), angioedema, and bronchospasm.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- No significant systemic drug interactions due to virtually zero gastrointestinal absorption.
- Avoid simultaneous use of chlorhexidine mouthwash without spacing, as binding may diminish antifungal efficacy.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Because systemic absorption from the gastrointestinal tract is negligible, nystatin oral suspension is the first-line antifungal of choice for oral thrush during pregnancy. No teratogenic effects have been reported.
Lactation & Breastfeeding:
Nystatin is not absorbed systemically and is not excreted into breast milk. It is safe for nursing mothers and is commonly used concurrently to treat maternal nipple candidiasis and infant thrush.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store between 2°C and 25°C (36°F to 77°F). Shake well before each use.
⏱️ Missed Dose Protocol:
Administer the missed dose as soon as remembered. If close to the next scheduled dose, skip and resume regular 4-times-daily routine. Do not double up doses.
Because nystatin is not absorbed systemically, massive oral overdose produces only transient nausea, vomiting, and diarrhea. Supportive therapy is sufficient.
Clinical Sources & Regulatory References
Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.
Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:
Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).
CDSCO Official Portal →U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.
Search FDA Labels on DailyMed →WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).
WHO Essential Medicines Registry →National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.
Query PubMed Studies for Nystatin →
4mg Clinical Pharmacology Team. Nystatin Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/nystatin/
